tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PLRX Stock Latest News

Cautious Hold Rating on Pliant Therapeutics Amid Clinical and Financial Uncertainties
RatingsCautious Hold Rating on Pliant Therapeutics Amid Clinical and Financial Uncertainties
10d ago
PLRX
Cautious Hold Rating for Pliant Therapeutics Amidst Strategic Restructuring and Drug Development Uncertainties
PremiumRatings
Cautious Hold Rating for Pliant Therapeutics Amidst Strategic Restructuring and Drug Development Uncertainties
10d ago
PLRX
PLRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PLRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
12d ago
PLRX
Pliant Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Pliant Therapeutics Reports Q1 2025 Financial Results
13d ago
PLRX
Pliant Therapeutics reports Q1 EPS (92c), consensus (62c)
PremiumThe Fly
Pliant Therapeutics reports Q1 EPS (92c), consensus (62c)
14d ago
PLRX
Pliant Therapeutics reports Q1 EPS (92c), consensus (75c)
PremiumThe FlyPliant Therapeutics reports Q1 EPS (92c), consensus (75c)
14d ago
PLRX
Pliant Therapeutics to reduce workforce by 45%
Premium
The Fly
Pliant Therapeutics to reduce workforce by 45%
21d ago
PLRX
Pliant Therapeutics Announces Major Workforce Reduction
Premium
Company Announcements
Pliant Therapeutics Announces Major Workforce Reduction
21d ago
8K
PLRX
Hold Rating on Pliant Therapeutics Amid Uncertainty and Limited Data from Early-Stage Trials
PremiumRatings
Hold Rating on Pliant Therapeutics Amid Uncertainty and Limited Data from Early-Stage Trials
2M ago
PLRX
Neutral Rating on Pliant Therapeutics Amid Early Promising Data and Uncertainties
PremiumRatings
Neutral Rating on Pliant Therapeutics Amid Early Promising Data and Uncertainties
2M ago
PLRX
Pliant Therapeutics announces interim Phase 1 data from PLN-101095
PremiumThe Fly
Pliant Therapeutics announces interim Phase 1 data from PLN-101095
2M ago
PLRX
Pliant Therapeutics Adopts Stockholder Rights Agreement
PremiumCompany Announcements
Pliant Therapeutics Adopts Stockholder Rights Agreement
2M ago
8K
PLRX
Pliant Therapeutics adopts limited duration stockholder rights agreement
PremiumThe FlyPliant Therapeutics adopts limited duration stockholder rights agreement
2M ago
PLRX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ADMA
ALDX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ALDX
ANRO
Hold Rating on Pliant Therapeutics Amid Trial Discontinuation and Safety Concerns
PremiumRatings
Hold Rating on Pliant Therapeutics Amid Trial Discontinuation and Safety Concerns
3M ago
PLRX
Okta upgraded, Quest Diagnostics downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Okta upgraded, Quest Diagnostics downgraded: Wall Street’s top analyst calls
3M ago
DV
LH
Pliant Therapeutics: Hold Rating Maintained Amid Trial Discontinuation and Adjusted Financial Outlook
PremiumRatings
Pliant Therapeutics: Hold Rating Maintained Amid Trial Discontinuation and Adjusted Financial Outlook
3M ago
PLRX
Pliant Therapeutics price target lowered to $1.50 from $4 at Citi
PremiumThe Fly
Pliant Therapeutics price target lowered to $1.50 from $4 at Citi
3M ago
PLRX
Cautious Hold Rating on Pliant Therapeutics Amid Uncertainty Over Bexotegrast Trial and Financial Outlook
PremiumRatingsCautious Hold Rating on Pliant Therapeutics Amid Uncertainty Over Bexotegrast Trial and Financial Outlook
3M ago
PLRX
Pliant Therapeutics reinstated with a Neutral at Cantor Fitzgerald
Premium
The Fly
Pliant Therapeutics reinstated with a Neutral at Cantor Fitzgerald
3M ago
PLRX
Hold Rating on Pliant Therapeutics Amidst BEACON-IPF Study Discontinuation and Uncertainty in Pipeline Prioritization
Premium
Ratings
Hold Rating on Pliant Therapeutics Amidst BEACON-IPF Study Discontinuation and Uncertainty in Pipeline Prioritization
3M ago
PLRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >